ArticlePloS one2023

A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.

Sivasankar Kanankulam Velliangiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.